[DNLI] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
27-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -20.25%
YoY- -21.07%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue -305,043 10,283 12,514 316,815 4,672 125,676 145,149 -
PBT -119,443 -98,684 -75,836 245,708 -53,950 77,533 -22,887 31.68%
Tax 30 -6 -575 823 75 -2,379 -807 -
NP -119,473 -98,678 -75,261 244,885 -54,025 77,533 -22,887 31.69%
Tax Rate - - - -0.33% - 3.07% - -
Total Cost -185,570 108,961 87,775 71,930 58,697 48,143 168,036 -
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 39.17 -959.62 -601.41 77.30 -1,156.36 61.69 -15.77 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.86 -0.74 -0.62 2.04 -0.57 0.82 -0.74 2.53%
EPS Diluted -0.86 -0.74 -0.62 1.91 -0.56 0.79 -0.74 2.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.